This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Emory University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Jamie Arnst: Innovator in Cancer Management
Introduction
Jamie Arnst is a notable inventor based in Atlanta, GA, who has made significant contributions to the field of cancer management. His innovative work focuses on bis-biguanide compounds and their pharmaceutical applications in treating various forms of cancer, particularly lung cancer.
Latest Patents
Jamie Arnst holds a patent for "Bis-biguanide compounds, pharmaceutical compositions and uses in managing cancer." This patent outlines methods for managing cancer using bis-biguanide compounds, such as alexidine. The disclosure emphasizes the treatment of lung cancer by administering an effective amount of these compounds to patients diagnosed with the disease. In particular, it addresses small cell lung cancer, providing a potential therapeutic avenue for those affected.
Career Highlights
Arnst is affiliated with Emory University, where he continues to advance his research in cancer treatment. His work is characterized by a commitment to developing effective pharmaceutical solutions that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Adam Marcus and Jessica Konen, who contribute to the collaborative research environment at Emory University.
Conclusion
Jamie Arnst's innovative work in the field of cancer management exemplifies the impact of research and development in pharmaceuticals. His contributions are paving the way for new treatment options for patients battling lung cancer.